FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

ANI Pharmaceuticals Dextroamphetamine Saccharate Recall

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulf…

ANI Pharmaceuticals, Inc. · Baudette, MN

Risk level
Class III
Reported by FDA
Oct 28, 2020
Recall ID
D-0046-2021
Check your lot numberHow we source this data

Summary

ANI Pharmaceuticals recalled Dextroamphetamine Saccharate starting Oct 9, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0046-2021 on Oct 28, 2020. Reason: Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months. Status: Terminated.

Why it was recalled

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Product description

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 20 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-280-10

Lot numbers, UPCs & expiration codes

Lot: 19T15 Exp. Dec. 2021, 20D02, 20D03 Exp. Mar. 2022

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0046-2021
Classification
Class III
Status
Terminated
Recall initiated
Oct 9, 2020
FDA report date
Oct 28, 2020
Quantity
24972 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
ANI Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0046-2021, exactly as published.

Show all FDA fields
City
Baudette
State
MN
Status
Terminated
Country
United States
Event ID
86584
Address
455 Idc Rd Sw
Code information
Lot: 19T15 Exp. Dec. 2021, 20D02, 20D03 Exp. Mar. 2022
Postal code
56623-2467
Report date
Oct 28, 2020
Product type
Drugs
Recall number
D-0046-2021
Classification
Class III
Recalling firm
ANI Pharmaceuticals, Inc.
Product quantity
24972 bottles
Termination date
Jan 19, 2022
Reason for recall
Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 20 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-280-10
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Oct 9, 2020
Initial firm notification
Letter
Center classification date
Oct 21, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0046-2021, published Oct 28, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls